SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.43-0.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1706)5/17/2007 9:10:55 AM
From: Icebrg   of 2240
 
Bad luck for IMGN. He will have to resign almost as soon as he was appointed.

ImmunoGen, Inc. Announces Resignation of Howard Pien from its Board of Directors
Thursday May 17, 9:00 am ET
Mr. Pien's New Position with Medarex Creates a Conflict of Interest

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN - News) today announced the resignation of Howard Pien from the Company's Board of Directors. Mr. Pien recently accepted the position of president and chief executive officer of Medarex, Inc. Since ImmunoGen and Medarex both develop antibody-based anticancer therapeutics, Mr. Pien's new role with Medarex creates a conflict of interest with his role as a Director of ImmunoGen. The Company has initiated a search to replace Mr. Pien on its Board.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext